THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
Life Sciences: Biotech

Vaccine for cancer finds a patron

$50m pledge will help Therion develop drug

By Stephen Heuser
Globe Staff / December 26, 2005

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

In an unusual effort by a single wealthy investor to keep a medical idea alive, a German billionaire is promising $50 million to Therion Biologics Corp., a small Cambridge company trying to develop the first-ever therapeutic vaccine for cancer. (Full article: 1076 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass